Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children. The report from the Washington Post said officials plan to include the claim in a presentation next week to a key vaccine panel that advises the Centers for Disease Control and Prevention. That committee play ...

特朗普要求制药公司证明新冠药物有效性 - 美国总统特朗普要求制药公司证明其新冠药物的成功性 并质疑部分人群对药物效果的争议性评价[1][2] - 特朗普通过社交媒体强调制药公司需公开药物效果数据以澄清公众质疑 并使用"extraordinary"描述已获知的辉瑞数据但未公开[2][4] - 特朗普要求制药公司立即提高数据透明度 使用"clear up this MESS"表述当前混乱局面[5] 美国食品药品监督管理局疫苗政策变化 - FDA最新批准的新冠疫苗仅限重症高风险人群接种 较此前适用范围显著收窄[2] - 该政策调整发生在特朗普要求制药公司证明药效的前几天 形成政策联动效应[1][2] 美国疾控中心人事动荡与政策改革 - 美国疾控中心主任Susan Monarez因拒绝辞职被解雇 另有四名高级卫生官员包括国家免疫与呼吸疾病中心主任Demetre Daskalakis离职[3] - 卫生与公众服务部部长Robert F Kennedy Jr实施系列机构改革措施 包括大规模裁员 解散政府疫苗咨询委员会和取消mRNA疫苗技术研究[4] - 人事变动导致CDC机构运作受到严重影响 被描述为"ripped apart"状态[4] 制药行业数据披露争议 - 特朗普声称获得辉瑞等制药公司未向公众披露的非凡药效数据 质疑其保密原因[4] - 行业被要求立即公开所有研究结果 特别是关于新冠药物的有效性证明[2][5]

In this article A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies are on different paths. Both Moderna and BioNTech helped pioneer mRNA, or messenger RNA, technology. Moderna staked its entire identity around mRNA, while BioNTech saw it as one piece of a broader portfolio focused on im ...